Search research articles
Contact Us
Filters
Showing results (211-220 of 234) with videos related to
Page
of 24
Sort By:
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1
E David Crawford, Alan H Bryce, Maha H Hussain, et al.
The Journal of Urology
|
February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
Peter S Kirk, Yair Lotan, Homayoun Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
European Urology Oncology
|
January 11, 2021
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
European Urology
|
September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Homayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 234) with videos related to
Sort By:
Page
of 24
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
JU Open Plus
|
May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1
E David Crawford, Alan H Bryce, Maha H Hussain, et al.
The Journal of Urology
|
February 16, 2023
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
Peter S Kirk, Yair Lotan, Homayoun Zargar, et al.
World Journal of Urology
|
August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology
|
September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Clinical Genitourinary Cancer
|
May 16, 2025
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Dimitra Rafailia Bakaloudi, Rafee Talukder, Thomas Enright, et al.
European Urology Oncology
|
January 11, 2021
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, et al.
Urologic Oncology
|
February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
Urologic Oncology
|
November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Anna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
European Urology
|
September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Homayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
Page
of 24